New Biology Economy

New Biology Economy tracks news of the emerging molecular biology tools marketplace, which is building on foundational biotechnical advances to create new insights into complex biological systems. This blog begins with the understanding that traditional business methods must change to enable innovation to create wealth and eventually benefit patients. This will require cooperation, new ways of protecting intellectual property, and will spawn new types of business organizations.

Google
WWW New Biology Economy

Monday, September 12, 2005

Randox Biochip-based Test for Drugs of Abuse Gets FDA Clearance: Report

  • Randox Laboratories of Northern Ireland has received FDA clearance for a biochip technology, its “Drugs of Abuse” array, which allows the simultaneous detection of amphetamine, methamphetamine, cocaine, barbiturates, cannabinoids, opiates, methadone, benzodiazepines, lorazepam, phencyclidine and creatinine from a single urine sample, according to a report published today on the Laboratorytalk website.

    The test is based on a biochip developed by Randox to run on its “evidence” system, which is an automated protein analysis platform that the company says can be used to conduct as many as 25 or more single sample tests simultaneously from as many as 180 patients per hour on a 1-square centimeter chip.

    The Evidence analyzer automates assays for the biochips. The analyzer consists of a twin carousel, which is designed to enable continuous operation of the system, and a loading area, a reagent/sample addition station, an incubator, wash station, signal station, and imaging station.

  • 0 Comments:

    Post a Comment

    << Home

    Blogarama - The Blog Directory Business Blog Top Sites